Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.
The U.S. is one of 23 countries that consider workforce AI training and education only a medium priority. Indeed, our homeland has a less detailed plan than 13 other nations.
The legal case brought by all 50 states, Washington D.C., and multiple U.S. territories against Purdue Pharma and the Sackler family has come to an end, with settlement funds set to be used for addiction recovery.
A class-action lawsuit claims CVS Health sent text messages to customers and patients, inciting fear over a PBM regulation up for vote in Louisiana. Plaintiffs allege the incident violates state data privacy and political communication laws.
A “sophisticated cybercrime group” is being blamed for an attack on the network of the private insurer, which may have exposed social security numbers and protected health information. The incident is still being investigated.
A healthcare AI startup in Silicon Valley is partnering with a top-tier medical school—and hopefully a few good radiologists—to test a hypothesis that’s increasingly crucial to radiology.
GE HealthCare will be the name of the company’s healthcare business, while its energy portfolio will go under the moniker GE Vernova, and its aviation business will be dubbed GE Aerospace.
Portable MRI maker Hyperfine is touting a new capability in its Swoop scanner that may appeal to pediatric neurologists and neurosurgeons as well as neuroradiologists.
A machine learning system for planning spine surgery that also predicts post-op spinal alignment six months out has cleared the FDA’s 510(k) review process.
When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.